Literature DB >> 6662175

Changes in pituitary secretion after administration of branched-chain amino acids to patients with hepatic cirrhosis.

T Barreca, R Franceschini, V Messina, P Bottaro, E Rolandi.   

Abstract

Infusion of a mixture of branched-chain 1-amino acids (BCAA; isoleucine, leucine, and valine) in six male patients suffering from hepatic cirrhosis led to an increase in serum GH, while serum PRL was not affected. In the same patients arginine infusion stimulated GH and PRL release. These findings demonstrate that hypothalamo-pituitary responsiveness to amino acid stimulation is preserved in cirrhosis and that administration of these amino acids has some endocrine effect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662175     DOI: 10.1007/bf00542516

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

2.  Thyroid function and thyroid regulation in euthyroid men with chronic liver disease: evidence of multiple abnormalities.

Authors:  J R Green; E J Snitcher; N A Mowat; R P Ekins; L H Rees; A M Dawson
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

3.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

4.  Radioimmunoassay of human growth hormone.

Authors:  G M Molinatti; F Massara; E Strumia; F Pennisi; G A Scassellati; L Vancheri
Journal:  J Nucl Biol Med       Date:  1969 Jan-Jun

5.  Chronic hepatic encephalopathy. Long-term therapy with a branched-chain amino-acid-enriched elemental diet.

Authors:  H Freund; N Yoshimura; J E Fischer
Journal:  JAMA       Date:  1979-07-27       Impact factor: 56.272

6.  Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.

Authors:  E E Müller; F Salerno; D Cocchi; V Locatelli; A E Panerai
Journal:  Clin Endocrinol (Oxf)       Date:  1979-12       Impact factor: 3.478

7.  Prolactin response to arginine in normal subjects and in patients with hyperthyroidism.

Authors:  T Onishi; K F Itoh; K Miyai; K Shima; Y Kumahara
Journal:  J Clin Endocrinol Metab       Date:  1976-01       Impact factor: 5.958

8.  Patterns of hypothalamic-pituitary-gonadal dysfunction in men with liver disease due to differing etiologies.

Authors:  D H van Thiel; J S Gavaler; J A Spero; K M Egler; C Wright; A T Sanghvi; U Hasiba; J H Lewis
Journal:  Hepatology       Date:  1981 Jan-Feb       Impact factor: 17.425

9.  hyperprolactinemia of portal hypertension in rats.

Authors:  A G Bauer; W J de Greef; F H de Jong; J H Wilson; S W Lamberts
Journal:  Gastroenterology       Date:  1982-02       Impact factor: 22.682

10.  Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma.

Authors:  A R Smith; F Rossi-Fanelli; V Ziparo; J H James; B A Perelle; J E Fischer
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

View more
  1 in total

1.  Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy.

Authors:  Dimitrios Velissaris; Menelaos Karanikolas; Andreas Kalogeropoulos; Ekaterini Solomou; Panagiotis Polychronopoulos; Konstantinos Thomopoulos; Chrissoula Labropoulou-Karatza
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.